0.00Open5.10Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover7748.67%IV-13.74%PremiumJul 19, 2024Expiry Date5.39Intrinsic Value100Multiplier-6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8958Delta0.1120Gamma0.41Leverage Ratio-3.7454Theta0.0000Rho-0.37Eff Leverage0.0000Vega
LAVA Therapeutics Stock Discussion
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet